The overall goals of the Center are to: (1) Provide better access to standard laboratory analyses and facilities; (2) assist in recruitment of study patients with diabetes and suitable controls, and provide complex animal models such as primates for diabetes-related investigation; (3) foster the development and efficient use of new technologies relevant to diabetes research; (4) coordinate, stimulate and support collaborative studies between investigators interested in diabetes at the U of Washington; and (5) enhance the environment for research training of post doctoral fellows and predoctoral medical and basic science students interested in Diabetes and related metabolic and endocrine disorders. To accomplish these goals the Diabetes Endocrinology Research Center is organized around six core units: Administrative Core, Clinical Research Core, Cytohistochemistry Core, Immunoassay Core, Physiology Core and Tissue Culture Core. Through specific services provided,, these cores support the research of over 40 Affiliate investigators and 36 Associate investigators. This research covers the entire spectrum of diabetes investigation including (a) molecular, cellular and physiological regulation of metabolic hormones and the mechanism of hormone action, (b) etiology and pathogenesis of IDDM and NIDDM, (c) mechanism of hyperlipidemia and the role of lipoproteins in atherosclerosis, (d) etiology, pathogenesis, treatment and prevention of diabetic complications and (e) etiology and pathogenesis of obesity. In addition, the Center's Pilot and Feasibility and Molecular Studies Development Programs provide initial support for new investigators in the field of diabetes, new diabetes research by established investigators in other disciplines and encourages the application of molecular biology to problems in the field of diabetes. To enhance the scientific environment for diabetes research at the University of Washington, the Center's Enrichment Program provides a Seminar Series, Core Symposia, and Visiting Scientist Program.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK017047-23
Application #
2838032
Study Section
Special Emphasis Panel (ZDK1-GRB-C (O1))
Program Officer
Abraham, Kristin M
Project Start
1977-06-01
Project End
2002-11-30
Budget Start
1999-05-15
Budget End
1999-11-30
Support Year
23
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Mietlicki-Baase, Elizabeth G; Liberini, Claudia G; Workinger, Jayme L et al. (2018) A vitamin B12 conjugate of exendin-4 improves glucose tolerance without associated nausea or hypophagia in rodents. Diabetes Obes Metab 20:1223-1234
Gordon, Sharona E; Munari, Mika; Zagotta, William N (2018) Visualizing conformational dynamics of proteins in solution and at the cell membrane. Elife 7:
Olivo, Robert E; Davenport, Clemontina A; Diamantidis, Clarissa J et al. (2018) Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study. Nephrol Dial Transplant 33:992-1001
Uusitalo, Ulla; Lee, Hye-Seung; Andrén Aronsson, Carin et al. (2018) Early Infant Diet and Islet Autoimmunity in the TEDDY Study. Diabetes Care 41:522-530
Brault, Michelle; Olsen, Tayla M; Martinez, Jennifer et al. (2018) Intracellular Nucleic Acid Sensing Triggers Necroptosis through Synergistic Type I IFN and TNF Signaling. J Immunol 200:2748-2756
Hofsteen, Peter; Robitaille, Aaron Mark; Strash, Nicholas et al. (2018) ALPK2 Promotes Cardiogenesis in Zebrafish and Human Pluripotent Stem Cells. iScience 2:88-100
Hippe, Daniel S; Phan, Binh An P; Sun, Jie et al. (2018) Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy: An Analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/ Arterioscler Thromb Vasc Biol 38:673-678
Subramanian, Savitha; Goodspeed, Leela; Wang, Shari et al. (2018) Deficiency of Invariant Natural Killer T Cells Does Not Protect Against Obesity but Exacerbates Atherosclerosis in Ldlr-/- Mice. Int J Mol Sci 19:
James, Eddie A; Pietropaolo, Massimo; Mamula, Mark J (2018) Immune Recognition of ?-Cells: Neoepitopes as Key Players in the Loss of Tolerance. Diabetes 67:1035-1042
Liese, Angela D; Ma, Xiaonan; Ma, Xiaoguang et al. (2018) Dietary quality and markers of inflammation: No association in youth with type 1 diabetes. J Diabetes Complications 32:179-184

Showing the most recent 10 out of 1296 publications